44 Largest Movers From Yesterday

Gainers

• Xenon Prescription drugs Inc. (NASDAQ: XENE) shares climbed 101.9% to shut at $31.50 on Monday after the corporate introduced its part 2 research of XEN1101 for the therapy of epilepsy met all major and secondary endpoints.
• Elmira Financial savings Financial institution (NASDAQ: ESBK) gained 68.2% to shut at $22.70 after the corporate introduced it might be acquired by Group Financial institution System.
• Mexco Vitality Company (NYSE: MXC) rose 46.4% to settle at $16.97 after OPEC+ agreed to stick with an current pact to extend oil output by 400,000 bpd in November.
• Lion Group Holding Ltd. (NASDAQ: LGHL) climbed 26% to shut at $1.89 after the corporate introduced it was granted a Capital Markets Service License from the Financial Authority of Singapore.
• Superior Drilling Merchandise, Inc. (NYSE: SDPI) rose 23.7% to settle at $1.88 after OPEC+ agreed to stick with an current pact to extend oil output by 400,000 bpd in November.
• Ring Vitality, Inc. (NYSE: REI) gained 18.8% to shut at $3.54.
• Verb Expertise Firm, Inc. (NASDAQ: VERB) rose 18.5% to shut at $2.31.
• U.S. Effectively Providers, Inc. (NASDAQ: USWS) jumped 16.4% to settle at $2.98.
• New Idea Vitality, Inc. (NYSE: GBR) gained 14.4% to shut at $5.01.
• Arqit Quantum Inc.. (NASDAQ: ARQQ) jumped 13.4% to shut at $20.76 after declining round 9% on Friday.
• CONSOL Vitality Inc. (NYSE: CEIX) gained 13.4% to settle at $32.10.
• Earthstone Vitality, Inc. (NYSE: ESTE) rose 13.1% to shut at $10.78 after OPEC+ agreed to stick with an current pact to extend oil output by 400,000 bpd in November.
• Clene Inc. (NASDAQ: CLNN) surged 12.8% to shut at $7.53. Clene not too long ago introduced initiation of a second FDA expanded entry program with CNM-Au8 for folks residing with amyotrophic lateral sclerosis.
• Indonesia Vitality Company Restricted (NYSE: INDO) gained 12.3% to shut at $4.96.
• SilverBow Sources, Inc. (NYSE: SBOW) rose 11.8% to settle at $29.65 after OPEC+ agreed to stick with an current pact to extend oil output by 400,000 bpd in November.
• RedHill Biopharma Ltd. (NASDAQ: RDHL) jumped 11.7% to settle at $4.88 after the corporate reported additional evaluation of Part 2/3 information together with a 62% discount in mortality with oral opaganib in reasonably extreme COVID-19 sufferers.
• Salem Media Group, Inc. (NASDAQ: SALM) gained 10.4% to settle at $4.47 after gaining 9% on Friday.
• 4D pharma plc (NASDAQ: LBPS) gained 10.2% to shut at $6.83.
• Adverum Biotechnologies, Inc. (NASDAQ: ADVM) shares gained 10.1% to shut at $2.40 after the corporate introduced new long-term information from the OPTIC medical trial of ADVM-022 single, in-office intravitreal injection gene remedy in sufferers requiring frequent anti-VEGF injections for his or her neovascular or moist age-related macular degeneration.
• Teekay LNG Companions L.P. (NYSE: TGP) gained 9.6% to shut at $17.19 after Stonepeak introduced it is going to purchase the corporate in a $6.2 billion transaction.
• OpGen, Inc. (NASDAQ: OPGN) gained 6.5% to settle at $2.94 after the corporate introduced it obtained FDA clearance for Acuitas AMR gene panel. The corporate additionally offered a enterprise replace and introduced preliminary unaudited income and money place for Q3.
• Independence Contract Drilling, Inc. (NYSE: ICD) gained 5.6% to shut at $3.19.

Try these massive penny inventory gainers and losers

Losers

• Amplify Vitality Corp. (NYSE: AMPY) shares dropped 43.8% to settle at $3.23 on Monday following a southern California ocean oil spill from a rig operated by Amplify Vitality.
• Esports Applied sciences, Inc. (NASDAQ: EBET) dipped 24.8% to shut at $23.57. Esports Applied sciences not too long ago mentioned it acquired Aspire International’s B2C enterprise in a $75.9 million transaction.
• Owlet, Inc. (NYSE: OWLT) shares fell 23.5% to shut at $4.19.
• Progenity, Inc. (NASDAQ: PROG) dropped 21.8% to settle at $1.40.
• REGENXBIO Inc. (NASDAQ: RGNX) fell 19.7% to shut at $32.33.
• IonQ, Inc. (NYSE: IONQ) dipped 18.4% to settle at $7.51.
• Paltalk, Inc. (NASDAQ: PALT) fell 16.2% to shut at $8.44. The corporate not too long ago introduced it engaged ClearThink to steer its expanded investor relations program.
• Aemetis, Inc. (NASDAQ: AMTX) fell 15.1% to settle at $16.72. The corporate not too long ago signed an offtake settlement with Delta Air Traces for 250 million gallons of blended gasoline.
• Sylvamo Company (NYSE: SLVM) declined 15.1% to shut at $28.01.
• Omeros Company (NASDAQ: OMER) dropped 14.8% to shut at $7.28. Maxim Group downgraded Omeros from Purchase to Maintain.
• Tyra Biosciences, Inc. (NASDAQ: TYRA) fell 14.1% to shut at $14.75.
• Silverback Therapeutics, Inc. (NASDAQ: SBTX) fell 13.9% to shut at $10.05 after climbing 17% on Friday.
• Ensysce Biosciences, Inc. (NASDAQ: ENSC) dipped 13.9% to settle at $2.47.
• UpHealth, Inc. (NYSE: UPH) dropped 13.9% to shut at $2.61. UpHealth reported pricing of $40.25 million public providing of widespread inventory after the closing bell on Monday.
• Danaos Company (NYSE: DAC) fell 13.4% to shut at $70.89.
• Roivant Sciences Ltd. (NASDAQ: ROIV) dropped 13.1% to shut at $8.13.
• AlloVir, Inc. (NASDAQ: ALVR) fell 12.2% to settle at $22.82. AlloVir mentioned the FDA has granted orphan drug designation to its Posoleucel, an allogeneic, off-the-shelf, multi-virus particular T-Cell remedy, for the therapy of virus-associated hemorrhagic cystitis.
• ZIM Built-in Transport Providers Ltd. (NYSE: ZIM) fell 11.5% to shut at $43.86.
• Guardforce AI Co., Restricted (NASDAQ: GFAI) fell 11.1% to shut at $3.51. Guardforce AI Co., on Friday. introduced closing of $15 million underwritten public providing.
• Offerpad Options Inc. (NYSE: OPAD) fell 11.1% to settle at $7.51 after the corporate, on Friday, introduced a combined shelf providing.
• Biomerica, Inc. (NASDAQ: BMRA) tumbled 9.3% to shut at $5.63 after leaping 38% on Friday. Biomerica not too long ago entered right into a Provider Settlement with Walmart to promote its EZ Detect colorectal illness screening take a look at inside the Walmart retail system.
• Cyren Ltd. (NASDAQ: CYRN) shares fell 6.9% to shut at $0.5585. CYREN filed for resale of as much as 29.2 million abnormal shares.